Felix Schiele
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Receptor Mechanisms and Signaling 2
- Protein Degradation and Inhibitors 1
-
- IL-33, ST2, and ILC Pathways 1
- Co-authors
- Herbert Nar (4 shared papers)Joanne van Ryn (2 shared papers)Tobias Litzenburger (2 shared papers)John Park (1 shared paper)Eliud Sepulveda (1 shared paper)Keith A. Canada (1 shared paper)Amaury E. Fernández‐Montalván (3 shared papers)Pelin Ayaz (1 shared paper)
- Journals
- Analytical Biochemistry (1 paper)Blood (1 paper)Lara D. Veeken (1 paper)ImmunoHorizons (1 paper)mAbs (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Felix Schiele
13 papers receiving 694 citations
Felix Schiele's Hit Papers
Peers
Comparison fields: 5 of 85
- Internal Medicine 233
- Cardiology and Cardiovascular Medicine 350
- Hematology 59
- Critical Care and Intensive Care Medicine 19
- Molecular Biology 165
Countries citing papers authored by Felix Schiele
This map shows the geographic impact of Felix Schiele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Schiele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Schiele more than expected).
Fields of papers citing papers by Felix Schiele
This network shows the impact of papers produced by Felix Schiele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Schiele. The network helps show where Felix Schiele may publish in the future.
Co-authors
The 25 scholars most cited alongside Felix Schiele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A specific antidote for dabigatran: functional and structural characterization Hit paper breakdown → | 2013 | 440 |
| 2 | 2018 | 63 | |
| 3 | 2014 | 51 | |
| 4 | 2021 | 47 | |
| 5 | 2015 | 31 | |
| 6 | 2013 | 28 | |
| 7 | 2017 | 23 | |
| 8 | 2021 | 14 | |
| 9 | 2015 | 10 | |
| 10 | 1997 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2024 | 1 | |
| 13 | Structural And Biophysical Characterization of Antibody:antigen Complexes of Therapeutic Relevance | 2013 | 1 |
About Felix Schiele
Felix Schiele is a scholar working on Molecular Biology, Immunology, Surgery, Cardiology and Cardiovascular Medicine and Oncology, having authored 13 papers that have together received 719 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Computational Drug Discovery Methods (2 papers), Receptor Mechanisms and Signaling (2 papers), IL-33, ST2, and ILC Pathways (1 paper), Mass Spectrometry Techniques and Applications (1 paper), Hypothalamic control of reproductive hormones (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Internal Medicine (233 citations), Cardiology and Cardiovascular Medicine (350 citations), Hematology (59 citations), Critical Care and Intensive Care Medicine (19 citations) and Molecular Biology (165 citations). Felix Schiele has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Herbert Nar, Joanne van Ryn, Tobias Litzenburger, John Park, Eliud Sepulveda, Keith A. Canada, Amaury E. Fernández‐Montalván, Pelin Ayaz, Victoria Georgi and John Park. Their work appears in journals such as Analytical Biochemistry, Blood, Lara D. Veeken, ImmunoHorizons and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.